Springer Graig

Springer Graig is listed in filings as Director at Hoth Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 15, 2025, including 3 public disclosures. Recent filings connect the profile to Hoth Therapeutics, Inc. (RKTO). The current snapshot covers public activity from Aug 21, 2024 to Jan 15, 2025. Reported amounts are shown as $18.9K to $108.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.